Preclinical Evidence and Underlying Mechanisms of Polygonum Multiflorum and Its Chemical Constituents Against Cognitive Impairments and Alzheimer’s Disease
June 2024
in “
Journal of pharmacopuncture
”
Studysummary This review compiles current experimental research on Alzheimer's and cognitive impairment models, highlighting the potential of *Polygonum multiflorum* for treating neurological disorders and suggesting a foundation for future clinical trials. Our plain-language summary of this paper — not a Tressless recommendation.
The review compiles current experiments on Alzheimer's Disease (AD) and cognitive impairment models, focusing on the therapeutic effects of Polygonum multiflorum. It highlights the potential of this plant and its chemical constituents in treating neurological disorders, suggesting that these findings could inform future clinical trials. The review emphasizes the promise of Polygonum multiflorum in addressing cognitive impairments and AD, providing a foundation for further research in human applications.
